CDNA vs GRAL
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 10, 2026
CDNA
GRAL
Investment Advisor Scores
GRAL
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CDNA | GRAL | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 68.9655 | 1.1658 | GRAL |
| PEG Ratio | -0.12 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 39.3% | 3.7% | CDNA |
| Earnings Growth | 1066.7% | 0.0% | CDNA |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 25.1/100 | 51.6/100 | GRAL |
| Profit Margin | 25.9% | -243.8% | CDNA |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | HOLD | GRAL |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CDNA
MarkupPrice above SMA50, rising 50-day trend (20.0% over 20 days), RSI 59
GRAL
NeutralMixed signals - no dominant trend phase, RSI 47
Fundamentals Snapshot
| Metric | CDNA | GRAL |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 51.2 | -15.6 |
| Trailing P/E | 35.6 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.4% | 0.0% |
| Gross Margin | 0.7% | 0.5% |
| Operating Margin | 0.1% | -3.9% |
| EPS | 2.37 | -9.22 |
| Dividend Yield | — | — |